Tesamorelin tracker
for iPhone.
Tesamorelin is the prescription end of the GHRH family — FDA-approved as Egrifta for HIV-related visceral fat reduction, then borrowed into longevity and body-recomposition self-protocols. The cadence is daily, the math is unfussy, and the discipline is "actually do it every night for twelve weeks." Peptide Protocol sits in the middle of that loop and keeps the streak honest.
Download Peptide Protocol — FreeTesamorelin at a glance
Quick reference for the protocol-builder. For the Egrifta prescribing information and the visceral-fat literature, follow the cross-link to our sister site.
| Class | GHRH analog (long-chain, stabilized) |
|---|---|
| Brand names | Egrifta (Theratechnologies) — FDA-approved for HIV-associated lipodystrophy |
| Plasma half-life | ~26 minutes (short-acting) |
| Typical cadence | Daily, nightly subcutaneous |
| Typical dose range | 1 mg per day per FDA label; some self-protocols use 2 mg |
| Common reconstitution | 2 mg vial + 2 mL bacteriostatic water → 1 mg/mL → 1.0 mL = 1 mg dose |
| Insulin syringe | U-100 (100 units = 1.0 mL = 1 mg at 1 mg/mL); U-50 viable for half-doses |
| Common stack pairings | Ipamorelin (alternative GHRP); occasionally MK-677 oral for compounded GH-axis support |
| Cycle length | 12-week protocol per FDA trials; many self-protocols run 8–12 week cycles with 4-week breaks |
For visceral-fat trial data, side-effect literature, and the comparison against CJC-1295, see the Tesamorelin guide on peptide-calc.app.
Built around Tesamorelin protocols
Three things daily GHRH protocols actually need.
Daily streak that survives travel
12-week protocols don't survive forgotten doses. The Today screen shows tonight's dose and the streak count; iCloud-free local storage means the data is on the device that's with you, not in a cloud you have to log into.
Vial-friendly math
1 mg / 2 mg vials with the standard 1 mg/mL reconstitution land you at a full 1 mL on a U-100 — large but workable. The calculator displays it cleanly and flags when you're at the syringe's max volume.
Body-comp insights
Daily check-ins capture weight and waist measurement (the metric the FDA trial used). The Insights tab charts trend over the cycle so the visceral-fat hypothesis you started with can be checked against real numbers.
What it looks like
Tesamorelin tracking — common questions
Does Peptide Protocol have a Tesamorelin preset?
Yes. Tesamorelin ships as a calculator preset at the standard 1 mg / 2 mg vial strengths. Pick the vial mass, set the BAC water volume, target the dose, and the app outputs the syringe units. Most protocols sit at 1 mg or 2 mg per day with the same nightly timing.
Tesamorelin or CJC-1295 — which one fits in the app?
Both. They're both GHRH analogs but Tesamorelin is the FDA-approved one (for HIV-related lipodystrophy under brand name Egrifta), short-acting like Mod GRF, and used daily. CJC-1295 with DAC is long-acting, weekly. The protocol-builder handles either: pick the compound and the cadence follows.
Can I stack Tesamorelin with Ipamorelin?
Yes. Tesamorelin (GHRH) plus Ipamorelin (GHRP) is a common alternative to the CJC / Ipa blend. Run them as parallel protocols — one daily, one nightly with whatever timing you've chosen — and the Today screen surfaces both. Calculator math for each runs independently, so no cross-contamination.
Related peptide trackers
Track your Tesamorelin on your iPhone.
Free on the App Store. Builds your first protocol in under five minutes. No account required.
Download on the App StoreNot medical advice. Tesamorelin (Egrifta) is a prescription medication FDA-approved for HIV-related lipodystrophy. Off-label use is a clinical decision, not an app-driven one. The information on this page is informational and based on the Egrifta prescribing information. Always consult a licensed healthcare professional before starting, modifying, or stopping any compound. See the full Tesamorelin reference for primary sources.